Anna Morris KC addresses Module 4 Preliminary Hearing in Covid-19 Inquiry

14 September 2023

Anna Morris KC and Christian Weaver, instructed by Terry Wilcox at Hudgells Solicitors, represent over 1,000 people who have suffered an adverse reaction or bereavement as a result of the Covid-19 vaccine.

Yesterday, in their opening statement to the UK Covid-19 Inquiry preliminary hearing for Module 4, which will focus on vaccines and therapeutics, they highlighted the historic opportunity the Inquiry has to listen, acknowledge and record the experiences of the vaccine injured, and to radically reform the medical, psychological and financial support they receive.

Anna Morris KC leads the team which represents the Vaccine Injured and Bereaved UK, Scottish Vaccine Injury Group, and UK CV Family, alongside GCN’s Christian Weaver and Mark Bradley from Deans Court Chambers.

You can read a transcript of the hearing.

Media coverage of Anna’s appearance can be found below:
Daily Mail Online
The Herald

News

News

Upper Tribunal finds Vijay Jagadesham’s client was aged only 16 when he arrived in the UK following successful age assessment challenge

Garden Court North’s Vijay Jagadesham successfully represented ‘SMF’ in overturning age assessments which categorised him as an adult.

News

Pete Weatherby KC discusses Hillsborough Law on ‘Law and Disorder’ podcast ahead of Bill’s second reading

Pete Weatherby KC discusses Hillsborough Law's provisions and origin ahead of its second reading in Parliament today.

News

“Relentless stress” of Blackpool Council’s CPO process contributed to Alistair Taylor’s death, inquest finds

Garden Court North's Christian Weaver represented Alistair Taylor's family pro bono at the inquest into his death.

News

Court of Appeal grants Palestine Action co-founder Huda Ammori a judicial review

Garden Court North's Mira Hammad and Rosalind Burgin are among counsel representing Palestine Action co-founder Huda Ammori.

Sign up to our mailing list

Our mailing list is dedicated to professionals with an interest in our work.

Sign up